China Cardiac Biomarkers Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Cardiac Biomarkers Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Cardiac Biomarkers Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Cardiac Biomarkers Overall Market Size
2.1 China Cardiac Biomarkers Market Size: 2021 VS 2027
2.2 China Cardiac Biomarkers Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Biomarkers Players in China Market
3.2 Top China Cardiac Biomarkers Companies Ranked by Revenue
3.3 China Cardiac Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Biomarkers Companies in China Market, by Revenue in 2020
3.5 Companies Cardiac Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Biomarkers Players in China Market
3.6.1 List of Tier 1 Cardiac Biomarkers Companies in China
3.6.2 List of Tier 2 and Tier 3 Cardiac Biomarkers Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Cardiac Biomarkers Market Size Markets, 2021 & 2027
4.1.2 Troponin
4.1.3 CK-MB
4.1.4 Natriuretic Peptides - BNP and NT-proBNP
4.1.5 Myoglobin
4.1.6 Others
4.2 By Type - China Cardiac Biomarkers Revenue & Forecasts
4.2.1 By Type - China Cardiac Biomarkers Revenue, 2016-2021
4.2.2 By Type - China Cardiac Biomarkers Revenue, 2022-2027
4.2.3 By Type - China Cardiac Biomarkers Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Cardiac Biomarkers Market Size, 2021 & 2027
5.1.2 Acute Coronary Syndrome
5.1.3 Myocardial Infarction
5.1.4 Congestive Heart Failure
5.1.5 Others
5.2 By Application - China Cardiac Biomarkers Revenue & Forecasts
5.2.1 By Application - China Cardiac Biomarkers Revenue, 2016-2021
5.2.2 By Application - China Cardiac Biomarkers Revenue, 2022-2027
5.2.3 By Application - China Cardiac Biomarkers Revenue Market Share, 2016-2027
6 Cardiac Biomarkers Companies Profiles
6.1 Abbott
6.1.1 Abbott Company Details
6.1.2 Abbott Business Overview
6.1.3 Abbott Cardiac Biomarkers Introduction
6.1.4 Abbott Cardiac Biomarkers Revenue in China Market (2016-2021)
6.1.5 Abbott Recent Developments
6.2 Abbott
6.2.1 Abbott Company Details
6.2.2 Abbott Business Overview
6.2.3 Abbott Cardiac Biomarkers Introduction
6.2.4 Abbott Cardiac Biomarkers Revenue in China Market (2016-2021)
6.2.5 Abbott Recent Developments
6.3 F. Hoffmann-La Roche
6.3.1 F. Hoffmann-La Roche Company Details
6.3.2 F. Hoffmann-La Roche Business Overview
6.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Introduction
6.3.4 F. Hoffmann-La Roche Cardiac Biomarkers Revenue in China Market (2016-2021)
6.3.5 F. Hoffmann-La Roche Recent Developments
6.4 Advanced ImmunoChemical
6.4.1 Advanced ImmunoChemical Company Details
6.4.2 Advanced ImmunoChemical Business Overview
6.4.3 Advanced ImmunoChemical Cardiac Biomarkers Introduction
6.4.4 Advanced ImmunoChemical Cardiac Biomarkers Revenue in China Market (2016-2021)
6.4.5 Advanced ImmunoChemical Recent Developments
6.5 AgPlus Diagnostics
6.5.1 AgPlus Diagnostics Company Details
6.5.2 AgPlus Diagnostics Business Overview
6.5.3 AgPlus Diagnostics Cardiac Biomarkers Introduction
6.5.4 AgPlus Diagnostics Cardiac Biomarkers Revenue in China Market (2016-2021)
6.5.5 AgPlus Diagnostics Recent Developments
6.6 BG Medicine
6.6.1 BG Medicine Company Details
6.6.2 BG Medicine Business Overview
6.6.3 BG Medicine Cardiac Biomarkers Introduction
6.6.4 BG Medicine Cardiac Biomarkers Revenue in China Market (2016-2021)
6.6.5 BG Medicine Recent Developments
6.7 BioLegend
6.7.1 BioLegend Company Details
6.7.2 BioLegend Business Overview
6.7.3 BioLegend Cardiac Biomarkers Introduction
6.7.4 BioLegend Cardiac Biomarkers Revenue in China Market (2016-2021)
6.7.5 BioLegend Recent Developments
6.8 bioMérieux
6.8.1 bioMérieux Company Details
6.8.2 bioMérieux Business Overview
6.8.3 bioMérieux Cardiac Biomarkers Introduction
6.8.4 bioMérieux Cardiac Biomarkers Revenue in China Market (2016-2021)
6.8.5 bioMérieux Recent Developments
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Company Details
6.9.2 Bio-Rad Laboratories Business Overview
6.9.3 Bio-Rad Laboratories Cardiac Biomarkers Introduction
6.9.4 Bio-Rad Laboratories Cardiac Biomarkers Revenue in China Market (2016-2021)
6.9.5 Bio-Rad Laboratories Recent Developments
6.10 BODITECH MED
6.10.1 BODITECH MED Company Details
6.10.2 BODITECH MED Business Overview
6.10.3 BODITECH MED Cardiac Biomarkers Introduction
6.10.4 BODITECH MED Cardiac Biomarkers Revenue in China Market (2016-2021)
6.10.5 BODITECH MED Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Cardiac Biomarkers Market Opportunities & Trends in China Market
Table 2. Cardiac Biomarkers Market Drivers in China Market
Table 3. Cardiac Biomarkers Market Restraints in China Market
Table 4. Key Players of Cardiac Biomarkers in China Market
Table 5. Top Cardiac Biomarkers Players in China Market, Ranking by Revenue (2019)
Table 6. China Cardiac Biomarkers Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Cardiac Biomarkers Revenue Share by Companies, 2016-2021
Table 8. Companies Cardiac Biomarkers Product Type
Table 9. List of Tier 1 Cardiac Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cardiac Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Cardiac Biomarkers Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Cardiac Biomarkers Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Cardiac Biomarkers Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Cardiac Biomarkers Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Cardiac Biomarkers Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Cardiac Biomarkers Revenue (US$, Mn), 2022-2027
Table 17. Abbott Company Details
Table 18. Abbott Business Overview
Table 19. Abbott Cardiac Biomarkers Product
Table 20. Abbott Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Abbott Recent Developments
Table 22. Abbott Company Details
Table 23. Abbott Business Overview
Table 24. Abbott Cardiac Biomarkers Product
Table 25. Abbott Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Abbott Recent Developments
Table 27. F. Hoffmann-La Roche Company Details
Table 28. F. Hoffmann-La Roche Business Overview
Table 29. F. Hoffmann-La Roche Cardiac Biomarkers Product
Table 30. F. Hoffmann-La Roche Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 31. F. Hoffmann-La Roche Recent Developments
Table 32. Advanced ImmunoChemical Company Details
Table 33. Advanced ImmunoChemical Business Overview
Table 34. Advanced ImmunoChemical Cardiac Biomarkers Product
Table 35. Advanced ImmunoChemical Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Advanced ImmunoChemical Recent Developments
Table 37. AgPlus Diagnostics Company Details
Table 38. AgPlus Diagnostics Business Overview
Table 39. AgPlus Diagnostics Cardiac Biomarkers Product
Table 40. AgPlus Diagnostics Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 41. AgPlus Diagnostics Recent Developments
Table 42. BG Medicine Company Details
Table 43. BG Medicine Business Overview
Table 44. BG Medicine Cardiac Biomarkers Product
Table 45. BG Medicine Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 46. BG Medicine Recent Developments
Table 47. BioLegend Company Details
Table 48. BioLegend Business Overview
Table 49. BioLegend Cardiac Biomarkers Product
Table 50. BioLegend Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 51. BioLegend Recent Developments
Table 52. bioMérieux Company Details
Table 53. bioMérieux Business Overview
Table 54. bioMérieux Cardiac Biomarkers Product
Table 55. bioMérieux Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 56. bioMérieux Recent Developments
Table 57. Bio-Rad Laboratories Company Details
Table 58. Bio-Rad Laboratories Business Overview
Table 59. Bio-Rad Laboratories Cardiac Biomarkers Product
Table 60. Bio-Rad Laboratories Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Bio-Rad Laboratories Recent Developments
Table 62. BODITECH MED Company Details
Table 63. BODITECH MED Business Overview
Table 64. BODITECH MED Cardiac Biomarkers Product
Table 65. BODITECH MED Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 66. BODITECH MED Recent Developments
List of FiguresFigure 1. Cardiac Biomarkers Segment by Type
Figure 2. Cardiac Biomarkers Segment by Application
Figure 3. China Cardiac Biomarkers Market Overview: 2020
Figure 4. China Cardiac Biomarkers Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Cardiac Biomarkers Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Cardiac Biomarkers Revenue in 2020
Figure 7. By Type - China Cardiac Biomarkers Revenue Market Share, 2016-2027
Figure 8. By Application - China Cardiac Biomarkers Revenue Market Share, 2016-2027
Figure 9. Abbott Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Abbott Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. F. Hoffmann-La Roche Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Advanced ImmunoChemical Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. AgPlus Diagnostics Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. BG Medicine Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. BioLegend Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. bioMérieux Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Bio-Rad Laboratories Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. BODITECH MED Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)